Advanced Oncotherapy (LSE:AVO) Long-Term Capital Lease Obligation : £33.04 Mil (As of Jun. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Long-Term Capital Lease Obligation?

Advanced Oncotherapy's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2022 was £33.04 Mil.

Advanced Oncotherapy's quarterly Long-Term Capital Lease Obligation increased from Jun. 2021 (£31.27 Mil) to Dec. 2021 (£32.20 Mil) and increased from Dec. 2021 (£32.20 Mil) to Jun. 2022 (£33.04 Mil).

Advanced Oncotherapy's annual Long-Term Capital Lease Obligation declined from Dec. 2019 (£31.05 Mil) to Dec. 2020 (£30.93 Mil) but then increased from Dec. 2020 (£30.93 Mil) to Dec. 2021 (£32.20 Mil).

Advanced Oncotherapy Long-Term Capital Lease Obligation Historical Data

The historical data trend for Advanced Oncotherapy's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Long-Term Capital Lease Obligation Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

31.05

30.93

32.20

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															31.62	30.93	31.27	32.20	33.04

Advanced Oncotherapy (LSE:AVO) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Advanced Oncotherapy Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.